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The COVID-19 pandemic necessitates implementation of exposure control measures
in all facets of the healthcare sector. Healthcare professionals who work in busy
ophthalmology clinics and theaters are amidst the highest at-risk of contracting COVID-
19. The authors review the up-to-date scientific evidence of SARS-CoV-2 transmission to
demystify and explain the exposure control options available for ophthalmic workplace
and offer insights from an industrial hygiene standpoint. As the we enter the post-COVID
world, these measures will be critical to enhance workplace safety, and thus protect
patients and staff alike.
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INTRODUCTION
COVID-19, caused by novel severe acute
respiratory syndrome coronavirus 2 (SARS-
CoV2), was declared a pandemic by the World
Health Organization (WHO) on March 12, 2020.[1]
It has since displayed its destructive potential by
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overwhelming the hospital systems of some of the
most well-resourced countries and claiming over
360,000 fatalities in its wake.[2] Furthermore, the
cessation of nonurgent elective work in order to
increase capacity tomanage the predicted surge of
cases, whilst necessary, has had significant impact
on the care of patients with other comorbidities by
restricting access and delaying treatments.
Measures including national lockdowns,
enforcing social distancing measures, contact
tracing, universal masking, shielding of the
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vulnerable, and quarantining the infectedmay have
slowed the spread of the disease and reduced
impact. In fact, most countries have nowpassed the
peak of their COVID-19 cases. However, without
a vaccine there is little evidence to suggest
that the complete eradication of COVID-19 will
be achieved and experts predict recurrent post-
pandemic outbreaks. We have to accept that the
virus will be a part of our lives for the foreseeable
future.[3]
The challenge for healthcare professionals now
is to safely resume the necessary healthcare
services. The onus is to ensure that this time is used
as a valuable opportunity and collective expertise
is utilized to innovate genuine improvements for
the ultimate benefit of patients.
SARS-CoV-2 Description
SARS-CoV2 is a positive-sense single-
stranded RNA virus which infects cells in
the lower respiratory tract, gaining entry via
the ACE2 receptors, similar to SARS-CoV.[4]
Infected individuals can remain asymptomatic
or develop symptoms that are predominantly
on the respiratory pathological spectrum.[5, 6]
Most common symptoms experienced are mild in
nature and include anosmia, sore throat, cough,
fever, and myalgia; however 15% get affected by
severe pneumonia leading to acute respiratory
distress syndrome requiring intensive care.[6, 7]
The virus has a propensity to affect the elderly,
the comorbid, and the immunocompromised more
severely; however, this is not exclusive as an
increased viral dose and inoculation can also lead
to severe disease phenotype.[4, 8]
Early analysis by Liu et al (2020) has shown
that viral shedding and viral load found in the
nasopharyngeal mucosa are directly proportional
to the severity of symptoms experienced.[9] It has
also been shown that asymptomatic individuals
are capable of spreading the virus as well.[10]
SARS-CoV2 is highly efficient in its transmission
from person to person for a low infective dose,
and primarily spreads via respiratory droplets,
aerosols, and contact.[4] The total number of
particles and ratio of respiratory aerosols (<
5µm) to droplets (> 5µm) is directly proportional
to the airway effort and disruption involved in
breathing, speaking, coughing, or sneezing.[11–13]
This is important because larger droplets of
respiratory origin do not usually travel more
than 2 m, but smaller aerosolized particles
can travel further and remain in the air for
longer durations.[11, 14] For example, particles
with aerodynamic diameters of 0.5 and 10 µm will
settle 5 feet in 41 h and 8.2 min, respectively.[14]
These aforementioned facts make it scientifically
plausible that infected individuals constantly
spread the virus in their environment, where it
lasts in air attached to the aerosols, and also on
inanimate surfaces such as plastics for up to 72
h.[15]
Enhancing Safety in Ophthalmology Settings
Many eye units around the globe had come
to a halt during the pandemic. For example, in
the UK, the Royal College of Ophthalmologists
had recommended the suspension of all non-
urgent elective eye operations and postponement
of low-risk non-urgent outpatient clinics which
lasted approximately 12 weeks.[16] These
measures, whilst essential, had a significant
impact on the organization and delivery of
ophthalmic services. Ophthalmic units now
face the challenge of resuming services
with a tremendous increase in workload
through the added backlog which cannot be
ignored.
Ophthalmology is already one of the busiest
outpatient specialties in healthcare. Each patient’s
journey includes several healthcare personnel
interacting to undertake routine objective
assessments which is often followed by specialized
imaging. The clinical consultation can take an
average of 8 min and includes a close proximity
slit-lamp examination to systematically inspect the
eye and its adnexa. During the Wuhan outbreak of
COVID-19, nosocomial transmission was reported
to be highest in ENT and Ophthalmology.[17]
The standard high-volume practice observed
in ophthalmic units is therefore very high-risk
and cannot be underestimated in subjecting
staff and patients to contracting SARS-CoV-
2.
Thus, the resumption of effective ophthalmic
services mandates several key modifications
to safely diagnose and treat patients. Exposure
mitigation measures in the Ophthalmology need
to be specifically tailored including infection
control, engineering control, administrative
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control, and provision of appropriate protective
equipment.
Infection Control
• Regular handwashing with soap and running
water for 20 sec should be followed by staff.
Patients should also gel hands on entry to the
unit and before leaving. Upon arrival at home, they
should again wash hands
• Clinical interactive surfaces should be cleaned
with alcohol-based or bleach-based disinfectants.
This is also true for slit-lamp and imaging devices.
• All personnel in the eye department should be
instructed never to touch face. This is to ensure that
there is protection of all mucous membranes; eyes,
nose, and mouth.
• There should be strict non-touch of all surfaces
unless unavoidable.




• Emergency eye services should continue to
run as a priority to provide timely care to those
absolute emergencies where there is a risk of loss
of sight.
• All emergency cases should undergo
telephone triage by a senior clinician to ascertain
the urgency of review and/or provide reassurance.
An effective alternative is to utilize video
consultations, such as the NHS’s Attend Anywhere,
which has reduced ophthalmic A&E attendances
by 30%. The success of the video consultations has
pushed for its development in other ophthalmic
specialties.
• It is also recommended that clinicians use
a standardized questionnaire during appointment
bookings and selection to flag out high-risk
patients based on reported symptoms and contact
history.
Routine Clinics
• Restarting clinical work will require case
selection so as to reduce any excessive and
avoidable exposure to staff and patients, many
of whom are elderly and at an increased risk of
becoming infected leading to severe illness with a
high mortality rate.
• Stratification systems to prioritize patients will
need to be developed on the basis of potential
harm and urgency due to delay. Patients who have
been postponed and now require urgent treatment
will need to have virtual reviews with their notes to
classify and prioritize their reviews/treatment.
• Face-to-face time and slots in clinics still need
to be minimized. Virtual clinics and telephone
triage should be done in specially designated
clinics with the patients’ notes available. This can
be used to identify patients that necessitate further
checks, examination, or procedures in person.
Such patients can then be booked into designated
face-to-face clinics.
• There should be a dedicated patient-
accessible eye hospital website detailing
information about common ophthalmic conditions
and procedures vetted by the ophthalmologists
of that institution. There can be supportive
video content exploring expectations of different
procedures to educate the patient.
• Hospitals must invest in IT infrastructure for
safe remote prescribing by liaising with local
and regional pharmacies. This will aid repeat
prescriptions and allow clinicians to review any
continuing treatments, such as for glaucoma
patients.
Surgical Theatres
• General anesthetic in all cases should be
considered only when absolutely necessary due
to intubation being considered as an aerosol-
generating procedure (AGP). Local anesthetic, if
possible, should be explained to patients and
considered.
• Careful consideration needs to be given
to cases requiring surgical methods involving
exploration of the orbit with high-speed drills
should be avoided as it generates aerosols.
• Only operating on absolute emergencies
where there is a risk of loss of sight during the
pandemic and any further waves of infection.
• Patients undergoing elective procedures
should self-isolate for two weeks before the
surgery and undergo COVID testing (Antigen PCR)
48 h before the surgery.
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Clinical Pathways
• Patient pathways and flow through the
department needs to be carefully considered so
that least number of stations are visited for the
different tests and required examinations. The
pathways should also consider being seen by the
least number of professionals possible.
• Face-to-face clinics should operate on
specific time slots with well-staggered time
intervals. Patients should come alone, or with one
relative/carer.
• Patients should be encouraged to arrive at
a specific time and wait in car until called in for
their appointment. Upon entry, the patients must
be screened again for COVID-19 symptoms.
• Self-check in computerized stations should be
placed at the entrances where patient can register
for their appointment and staff can remotely inquire
about COVID-19 symptoms. There can also be
remote temperature-checking equipment for the
patient to self-check for fever. This can also be
used to take a history from the patient.
• Following the check-in, patient should be
allowed to enter the department. All patients
should cover their mouth and nose with medical
masks, cloth masks, or simply with a piece of cloth
(unless contraindicated). Upon entry, they should
be directed to the clinic room as quickly as possible
without any undue delay and waiting.
• Clinic room face-to-face meeting should be
primarily examination-based. All examinations
must be focused.
• All explanation and consultations after
examinations should be done remotely to reduce
face-to-face time and discussion in clinics.
• Conversations should also be kept to a
minimum and all patients should be instructed to
speak little. There should be no talk during the slit-
lamp examination.
• Departmental patient numbers should not
accrue more than an upper limit, which is defined
on the basis of physical space available and
ventilation.
Staff
• Staff should not accrue in rooms and maintain
a distance of at least 1 m at all times.
• There should not be any face-to-facemeetings,
and where possible telephone and e-meetings
should be organized instead.
• Universal masking throughout the premises




• There should be a red pathway for COVID
positive, symptomatic, and suspect patients who
necessitate examination, with a separate entrance
and exit and designated room for examination.
Red-labelled operating rooms should also be
separated.
• For all patients who are COVID-negative or
asymptomatic, there should be a green stream
involving a separate entrance and exit. There
should also be designated rooms for examination
and operating.
Outpatients
• There should be a designated separate
entrance and exit for all attending patients.
• Two separate doorways should be individually
designated and labelled as exit and entrance for
clarity of staff and patients alike.
• There should be flow markings on the
floor, and directions on the walls (similar to
supermarkets).
• Consider setting up a physical barrier (such as
a plexiglass wall) between reception and patient
area and adjust ventilation system to have the
reception area a positive pressure zone. This way,
any direct droplet and airborne particle spread can
be blocked from the patient areas.
•Waiting roommust have a seating arrangement
with a gap of at least 1 m between seats.
Clinics and Equipment
• Ophthalmic clinics must be conducted in
a designated well-ventilated room. Ventilation
systems should be fitted with high efficiency
particulate air (HEPA) filters to purify air in the
clinical areas. If this is not possible, windows can
be opened to maintain airflow in spacious rooms.
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• All slit lamps should bemodified to incorporate
a clear thick plastic or Perspex shield breath guards
with sufficient dimensions to provide cover for the
examining ophthalmologist and patient.
• In imaging clinics, the machinery can be
encompassed by a specialized Perspex box-type
enclosure with glove entrances. These enclosures
can be linked to the exhaust fanwith high efficiency
particulate air (HEPA) filter to create negative
pressure system for your operation.
Operating Theatres
• Operating theatres should be properly
ventilated to meet the designed air change
requirement or with ambient air recycled with
HEPA systems to reduce risk of aerosol spread
and deposition in the environment. ASHRAE
recommends 20 air changes per hour for operating
rooms.[18]
• There should be a designated separate
entrance and exit to the theatre.
Personal Protective Equipment
Personal protective equipment (PPE) provisions
are paramount in reducing transmission of SARS-
CoV-2 to the healthcare workers. Staff must also
be trained in the proper donning and doffing
procedures.
Eye protection
Eye protection encompasses several different
types of safety devices including safety goggles,
visors, and face shields. Ideally, eye protection
should be offered in the form of visors or goggles
that fit snugly by forming a seal around the eyes.
There have been case reports suggesting that
coronavirus is transmissible through conjunctival
tissue as well.[19]
Gloves and Gown
Gloves and gowns are recommended when
dealing with high-risk cases, particularly when
in an aerosol-generating environment. High-risk
areas are cohorted in most hospitals, so the
staff should refrain from deploy donning and
doffing repeatedly in these areas. PPE donning
should only be done in a designated clean
area while a separate designated area should
be used for PPE removal. This is because
doffing can shed virus that may become
airborne and contaminate bits of gear, face,
or hands. Every surface including used PPE
should be considered contaminated. Gloves
use should be mandatory to prevent cross-
contamination between hand-surface material
cross-contamination and when examining ocular
and adnexal tissues.
Masks and Respirators
Formal use of surgical masks has been
recommended at least since the early 1900s
to avoid droplet contamination during surgical
procedures.[20] Respiratory personal protection
is paramount as it protects the mucosa of
nose and mouth. Nowadays, there are various
types of surgical masks and respirators
available to the healthcare workforce (Table
1).[21, 22]
Surgical masks comprise of three layers: an
inner soft absorbent layer, a middle polypropylene
barrier, and an outer hydrophobic fabric which
mold to the user’s nasal bridge to cover nose,
mouth, and chin. They act as a barrier to infectious
droplets. They also assist in the maintenance of a
sterile field by reducing the spread of droplets from
the wearer’s nose and mouth.[13, 23, 24]
Filtering facepiece respirators (FFPs), on
the other hand, provide additional benefit to
surgical masks by providing an air-tight seal and
containing a mechanical filter, which can remove
airborne contaminants through interception.
Health and Safety Executive and British Safety
Industry Federation recommend fit testing to
ensure the respirator is suited to the user’s
facial structure and therefore performs optimally.
There are three categories of FFP in Europe:
FFP1, FFP2 (equivalent to N95), and FFP3. Class
three (FFP3) provides the highest quality of
protection and is the only one approved for
UK healthcare settings, especially in AGPs,
such as intubation and non-invasive ventilation.
They must meet industry-standard regulations
including strict industry tests with biological
aerosols and cannot exceed 2% leakage. FFP3
masks provide 99% efficiency in filtering particles
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sized above 100 nm, including small airborne
droplets.[22, 24]
Based on the scientific rationale provided in
this article and established practice in the Far-
Eastern countries, masks or facial coverings must
be worn by all patients and staff at all times.[25]
This reduces the spread of respiratory droplets in
the environment and deposition on fomites and
therefore protects from inhalation of virus-laden
aerosols. Close contact with symptomatic patients
who have more respiratory aerosol production
necessitates the use of respirators.
Conserving and Procuring Personal
Protective Equipment
It is envisioned that by streamlining the service
during the COVID-19 pandemic to exclusively treat
emergencies and operating on the life-, limb-, or
organ-threatening conditions, we would conserve
the limited supply of specialized protective
equipment necessary to provide safe care.
However, if this pandemic lasts for a longer
duration, with more and more people being
infected, then we may be threatening to fast
deplete our supply of resources and PPE kit with
the current model of single use or single session
use.
The issue of ensuring a steady supply of PPE
equipment will require commissioning production
of these items nationally. In the UK, industrial
plants that have machinery to produce face
shields or masks have already started to offer a
helping hand to the government by developing
and supplying PPE to hospitals. Similarly, there
are also in-house 3D printing technology centers
that can be used to make face shields, visors,
and goggles. Countries in short supply need to
explore the possibility of further importing from
China, where they now have spare capacity. As
large variation in quality in masks have been
reported, PPE procurement should obtain small
batch samples to verify PPE effectiveness prior to
mass ordering.
Given the finite resources, it is also paramount
that mask reusability and extended wear is
explored as a priority. Taiwan was able to
successfully limit its public to purchase a
maximum of two masks per week, which
allowed appropriate distribution to all and
enforced reuse.[26] Masks have been shown
to be reusable in studies using energetic
methods such as germicidal ultraviolet light
and microwaved steam.[27–29] US Food and
Drug Administration has given an emergency
go-ahead to a novel Battelle Critical Care
Decontamination SystemTM which uses vaporized
hydrogen peroxide to sterilize and does not
degrade filter performance of respirators.[30]
There are also unlicensed recommendations to
utilize autoclaves or ovens to sterilize masks
and perhaps that will be effective for a limited
number of cycles before the mask efficiency
degrades to substandard levels. In these
desperate times, we have no choice but to be
resourceful and adapt during this pandemic
by using the existing scientific knowledge of
decontamination with our understanding of SARS-
CoV-2 virus.[29]
Conserving Medical, Nursing, and Allied
Healthcare Workforce
Healthcareworkers are at themost risk of repetitive
exposure to this pathogen that increases their
viral load predisposing them to contracting severe
pneumonia and end up hospitalized. There have
several fatalities of frontline staff around the
world; in Italy, ∼8% of the total cases affected
were healthcare workers.[31] This risk is highest
to healthcare workers participating in AGPs and
to ENT and Ophthalmology staff who see an
increased outpatient load at close quarters.[17]
Risk assessment of BAME, co-morbid, and
older members of staff should be prioritized to
ensure safe working standards and appropriate
job roles are allocated. We also have to ensure
that staff are tested regularly to maintain a
strong battlefront against this pandemic. It should
also be compulsory for staff to self-monitor
twice daily temperatures and development of
infective symptoms, as was done in National
University Hospital, Singapore.[32] Depending on
the availability of tests, regular SARS-CoV-2 testing
should also be mandated for all working and
returning staff to prevent asymptomatic spread in
the healthcare workplace.[33]
Summary
Veni, vidi, vici. I came, I saw, I conquered. COVID-
19 came and unleashed untold harm to society
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Table 1. Comparison of different commonly used face mask/respirator in the market[21,22]
Mask Type Standards Filtration Effectiveness
Surgical Mask China YY 0469 3.0 microns ≥ 95%
0.1 microns ≥ 30%
USA ASTM F2100 Level 1 Level 2 Level 3
3.0 microns ≥ 95% 3.0 microns ≥ 98% 3.0 microns ≥ 98%
0.1 microns ≥ 95% 0.1 microns ≥ 98% 0.1 microns ≥ 98%
Europe EN 14683 Type I Type II Type III
3.0 microns ≥ 95% 0.3 microns ≥ 98% 0.3 microns ≥ 98%
0.1 microns X 0.1 microns X 0.1 microns X
Respirator Mask USA NIOSH (42 CFR 84) N95/KN95 N99/KN99 N100/KN100
China GB2626 0.3 microns ≥ 95% 0.3 microns ≥ 99% 0.3 microns ≥ 99.97%
Europe EN149 :2001 FFP1 FFP2 FFP3
0.3 microns ≥ 80% 0.3 microns ≥ 94% 0.3 microns ≥ 99%
3.0 microns: Bacteria Filtration standard (BFE)
0.1 microns: Particle Filtration Efficiency standard (PFE)
0.3 microns: Used to represent the most penetrating particle size
X: No requirements
and will linger on with possibility of further waves
unless it self-attenuates, or safe effective vaccines
arrive. In the light of current knowledge of COVID-
19, we have put together important considerations
for protecting patients and staff.
Primum non nocere – we need to be certain
that we are protecting patients from contracting the
coronavirus. At the same time, we also have a duty
of care to staff. There is not only a contractual duty
but a moral duty to protect medical, nursing, and
other healthcare staff. Conserving highly trained
healthcare staff is of course a national interest.
The prevention of spread is done through
education, guidelines, rules, and the law. It
behooves governments and healthcare regulators
to put these in place. In a century’s time, we
want future ophthalmologists to be able to look
back and say their forebears had done well in the
year 2020 protecting ophthalmology patients and
staff and laid foundations for new pathways and
new ways of delivering safe ophthalmic care, thus
transforming ophthalmology despite the challenge
of high volume and high risk.
Financial Support and Sponsorship
None.
Conflicts of Interest
There are no conflicts of interest.
REFERENCES
1. WHO. WHO announces COVID-19 outbreak a




2. Johns Hopkins, School of Medicine. Coronavirus resource
center statistics [Internet]. Johns Hopkins University; 2020
[cited June 6, 2020]. Available from: https://coronavirus.
jhu.edu/map.html.
3. Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch
M. Projecting the transmission dynamics of SARS-
CoV-2 through the postpandemic period. Science
2020;368:860–868.
4. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ,
et al. The origin, transmission and clinical therapies on
coronavirus disease 2019 (COVID-19) outbreak - an update
on the status. Mil Med Res 2020;7:11.
5. Nishiura H, Kobayashi T, Suzuki A, Jung S-Mok, Hayashi K,
Kinoshita R, Yang Y, et al. Estimation of the asymptomatic
ratio of novel coronavirus infections (COVID-19). Int J Infect
Dis 2020;94:154–155.
6. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L,
et al. China Medical Treatment Expert Group for Covid-
19. Clinical characteristics of coronavirus disease 2019 in
China. N Engl J Med 2020;382:1708–1720.
7. Hopkins C, Kumar N. Loss of smell as a marker for
COVID-19 infection [Document]. ENT UK; 2020. Available
406 JOURNAL OF OPHTHALMIC AND VISION RESEARCH VOLUME 15, ISSUE 3, JULY-SEPTEMBER 2020




8. Heneghan C, Brassey J, Jefferson T. Oxford COVID-
19 Evidence Service Team. SARS-CoV-2 viral load
and the severity of COVID-19 [Internet]. Centre for
Evidence-Based Medicine; 2020. Available from:
https://www.cebm.net/covid-19/sars-cov-2-viral-load-
and-the-severity-of-covid-19/.
9. Liu Y, Yan L,Wan L, Xiang T, Le A, Liu J, et al. Viral dynamics
in mild and severe cases of COVID 19. Lancet Infect Dis
2020;20:656–657.
10. Lai CC, Liu YH, Wang CY, Wang YH, Hsueh SC, Yen
MY, et al. Asymptomatic carrier state, acute respiratory
disease, and pneumonia due to severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2): facts and myths.
J Microbiol Immunol Infect 2020:S1684–1182:30040–
30042.
11. Annex C. Respiratory droplets. In: Atkinson K, Chartier Y,
Pesso-Silva CL, Jensen P, Li Y, Seto W, editors. natural
ventilation for infection control in healthcare settings.
Geneva: WHO; 2009.
12. Zayas G, Chiang MC, Wong E, MacDonald F, Lange
CF, Senthilselvan A, et al. Cough aerosol in healthy
participants: fundamental knowledge to optimize droplet-
spread infectious respiratory disease management. BMC
Pulm Med 2012;12:11.
13. Leung NHL, Chu DKW, Shiu EYC, Chan K, McDevitt JJ, Hau
BJP, et al. Respiratory virus shedding in exhaled breath and
efficacy of face masks. Nat Med 2020;26:676–680.
14. ASHRAE. Position paper on infectious aerosols




15. Van Doremalen N, Bushmaker T, Morris DH, Holbrook
MG, Gamble A, Williamson BN, et al. Aerosol and surface
stability of SARS-CoV-2 as compared with SARS-CoV-1. N
Engl J Med 2020;382:1564–1567.
16. Royal College of Ophthalmologists. Management
of ophthalmology services during the Covid




17. China.org.cn. State Council Information Office briefing
on the science-based treatment of severe COVID-19
cases [Internet]. Wuhan, China: March 2020 [cited March
26, 2020]. Available from: http://www.china.org.cn/china/
2020-03/20/content_75839939.htm.
18. ANSI/ASHRAE/ASHE. Standard 170 - ventilation of health
care facilities. Atlanta, GA: ASHRAE; 2008. Available from:
http://sspc170.ashraepcs.org/pdf/170_2008_FINAL.pdf
19. Li JO, Lam DSC, Chen Y, Ting DSW. Novel Coronavirus
disease 2019 (COVID-19): the importance of recognising
possible early ocular manifestation and using protective
eyewear. Br J Ophthalmol 2020;104:297–298. Available
from: https://bjo.bmj.com/content/104/3/297.
20. Spooner JL. History of surgical masks. AORN J 1967;5:76–
80.
21. Robertson P. Comparison of masks standards, ratings and
filtration effectiveness [Internet]. Smart Air; 2020. Available
from: https://smartairfilters.com/en/blog/comparison-
mask-standards-rating-effectiveness/.
22. Lee SA, Hwang DC, Li HY, Tsai CF, Chen CW, Chen
JK. Particle size-selective assessment of protection of
European Standard FFP Respirators and Surgical Masks
against Particles-Tested with Human Subjects. J Healthc
Eng 2016;1–12. doi: 10.1155/2016/8572493.
23. Patel RB, Skaria SD, Mansour MM, Smaldone GC.
Respiratory source control using a surgical mask: an in
vitro study. J Occup Environ Hyg 2016:13;569–576.
24. Gawn J, Clayton M, Makeison C, Crook B. Evaluating the
protection afforded by surgical masks against influenza
bioaerosols: gross protection of surgical masks compared
to filtering facepiece respirators. Buxton: Health and Safety
Executive; 2008; 33.
25. Chan WM, Liu DT, Chan PK, Chong KK, Yuen KS, Chiu
TY, et al. Precautions in ophthalmic practice in
a hospital with a major acute SARS outbreak:
an experience from Hong Kong. Eye 2006:21;304–305.
26. Hsieh VC. Putting resiliency of a health system to the test:
COVID-19 in Taiwan. J Formos Med Assoc 2020:119;884–
885.
27. Heimbuch BK, Wallace WH, Kinney K, Lumley AE, Wu
CY, Woo MH, et al. A pandemic influenza preparedness
study: use of energetic methods to decontaminate filtering
facepiece respirators contaminated with H1N1 aerosols
and droplets. Am J Infect Control 2011:39:e1–e9.
28. Lore MB, Heimbuch BK, Brown TL, Wander JD, Hinrichs
SH. Effectiveness of three decontamination treatments
against influenza virus applied to filtering facepiece
respirators. Ann Occup Hyg 2012:56;92–101.
29. Lin M. How to fight coronavirus SARS-CoV-2 and its




30. BATELLE systemTM. Instructions for healthcare facilities:
preparation and collection of compatible N95 respirators
for decontamination by the Battelle Memorial Institute





31. Oke J, Heneghan C. Oxford COVID-19 evidence service
team. Global COVID-19 case fatality rates [Internet]. CEBM;
2020. Available at: https://www.cebm.net/covid-19/global-
covid-19-case-fatality-rates/.
32. Jun ISY, Hui KKO, Songbo PZ. Perspectives on
Coronavirus disease 2019 control: measures for
ophthalmology clinics based on a Singapore center
experience. JAMA Ophthalmol 2020;138:435–436.
Available from: https://jamanetwork.com/journals/
jamaophthalmology/fullarticle/2764085.
33. Rivett L, Sridhar S, Sparkes D, Routledge M, Jones NK,
Forrest S, et al. Screening of healthcare workers for SARS-
CoV-2 highlights the role of asymptomatic carriage in
COVID-19 transmission [published online ahead of print,
2020 May 11]. Elife 2020;9:e58728.
JOURNAL OF OPHTHALMIC AND VISION RESEARCH VOLUME 15, ISSUE 3, JULY-SEPTEMBER 2020 407
